Agilent, GKC-335300, AdvanceBio G3S3 α(2,6) / A3G3S(6)3 N-glycan Standard

AdvanceBio G3S3 α(2,6) / A3G3S(6)3 N-glycan Standard . N-glycan (tri-sialylated-, galactosylated triantennary complex). Qualitative standard for glycan identification. Alternative glycan names: G3S3, A3G(4)3S(6)3, A3.

Specifications:
Chemical Structure:
Label: Unlabeled
Monoisotopic Mass: 2879.0106
Name: G3S3 (α2,6)
Oxford Name: A3G(4)3S(6)3
Standard Type: Complex-type Native N-Glycan
Unit: 10 µg

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
This high-purity N-glycan standard is designed for precise analytical characterization in biopharmaceutical research and quality control. Containing well-defined G3S3 α(2,6)-linked and A3G3S(6)3 glycan structures, it enables accurate method development, system suitability testing, and robust performance verification of glycan analysis workflows. Optimized for use in HPLC, UHPLC, and mass spectrometry platforms, this standard supports detailed profiling, identification, and quantitation of complex glycan species in monoclonal antibodies or glycoprotein therapeutics. It is fully compatible with Agilent AdvanceBio Glycan Mapping columns, industry-standard fluorescence labeling, and associated bioanalytical systems, ensuring seamless integration into regulated or exploratory laboratory procedures. The consistent lot-to-lot quality and in-depth structural validation ensure reliable reproducibility for both routine and advanced glycomic applications. This standard is an essential tool for laboratories focused on biosimilar development, comparability studies, and release testing, facilitating regulatory compliance and high-confidence data generation. Comprehensive technical documentation and expert support are available to enhance ease-of-use for both academic and industrial researchers. Use this standard to streamline glycan workflow validation, instrument calibration, and data comparability across a range of biotherapeutic development and characterization projects.